SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-12-004019
Filing Date
2012-11-08
Accepted
2012-11-08 11:31:51
Documents
18
Period of Report
2012-09-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_110812.htm 8-K 23175
2 EXHIBIT 99.1 exh_991.htm EX-99.1 38901
3 EXHIBIT 99.2 exh_992.htm EX-99.2 12945
4 exh992_01.jpg GRAPHIC 111858
5 exh992_02.jpg GRAPHIC 194080
6 exh992_03.jpg GRAPHIC 138683
7 exh992_04.jpg GRAPHIC 148939
8 exh992_05.jpg GRAPHIC 207956
9 exh992_06.jpg GRAPHIC 137059
10 exh992_07.jpg GRAPHIC 174109
11 exh992_08.jpg GRAPHIC 140427
12 exh992_09.jpg GRAPHIC 181577
13 exh992_10.jpg GRAPHIC 183517
14 exh992_11.jpg GRAPHIC 201989
15 exh992_12.jpg GRAPHIC 204084
16 exh992_13.jpg GRAPHIC 154810
17 exh992_14.jpg GRAPHIC 171277
18 exh992_15.jpg GRAPHIC 123615
  Complete submission text file 0001171843-12-004019.txt   3486718
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 121188974
SIC: 2834 Pharmaceutical Preparations